drugset / Trial / NCT07487831

The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease

NCT07487831

Phase 4 Not yet recruiting 50 enrolled University of California, San Francisco LEO Foundation · collab
RandomizedCrossoverTriple-blindPrevention

Summary

The goal of this clinical trial is to demonstrate the feasibility of a trial that examines the impact of changes in dietary sodium intake on skin sodium levels, atopic dermatitis, and psoriasis. In addition, it aims to generate preliminary data to begin to answer the following questions: 1. Is there an association between skin sodium concentration and atopic dermatitis and psoriasis severity? 2. Are changes in dietary sodium are associated with changes in skin sodium concentration and atopic dermatitis and psoriasis severity? Researchers will compare sodium tablets to a placebo (a look-alike substance that contains no drug) to specifically examine the impact of altering sodium intake. Participants will: * Follow a low-salt diet for the duration of the 13-week study * Take sodium chloride tablets every day for 5 weeks followed by a placebo every day for 5 weeks after a 2-week washout period, or vice versa * Visit the clinic up to 4 times to answer questionnaires, provide bio samples, complete dietary recalls, and undergo non-contrast sodium MRI

Timeline

Start
2026-06-22
Primary completion
2028-03-17
Completion
2028-03-17

Drugs

EvaluationDrugModalityDoseRoute
Subject sodium chloride Unknown 1 g

Indications